{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:50:55Z","timestamp":1778601055954,"version":"3.51.4"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.metabol.2019.03.006","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T13:54:36Z","timestamp":1553176476000},"page":"36-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"special_numbering":"C","title":["Angiotensin-(1-7), Adipokines and Inflammation"],"prefix":"10.1016","volume":"95","author":[{"given":"Deborah de Farias","family":"Lelis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Fernanda de","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Souto","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tha\u00edsa Soares","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9rgio Henrique Sousa","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2019.03.006_bb0005","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2174\/0929866524666170728144357","article-title":"Renin-angiotensin system in diabetes","volume":"24","author":"Rein","year":"2017","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.metabol.2019.03.006_bb0010","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2174\/092986652409171117112901","article-title":"Editorial: renin-angiotensin system: role in chronic diseases","volume":"24","author":"Santos","year":"2017","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.metabol.2019.03.006_bb0015","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.tips.2015.03.001","article-title":"Angiotensins as therapeutic targets beyond heart disease","volume":"36","author":"Passos-Silva","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.metabol.2019.03.006_bb0020","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41440-018-0040-6","article-title":"The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review","volume":"41","author":"Borem","year":"2018","journal-title":"Hypertens Res"},{"key":"10.1016\/j.metabol.2019.03.006_bb0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.peptides.2014.07.002","article-title":"Angiotensin 1\u20137: a peptide for preventing and treating metabolic syndrome","volume":"59","author":"Santos","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.metabol.2019.03.006_bb0030","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.phrs.2016.07.025","article-title":"Angiotensin (1\u20137) and alamandine: similarities and differences","volume":"111","author":"Qaradakhi","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.metabol.2019.03.006_bb0035","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/01.HYP.0000253966.21795.d3","article-title":"Cross-talk between angiotensin II receptor types 1 and 2: potential role in vascular remodeling in humans","volume":"49","author":"Hernandez Schulman","year":"2007","journal-title":"Hypertension."},{"key":"10.1016\/j.metabol.2019.03.006_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.phrs.2017.07.008","article-title":"AT2 receptors in cardiovascular and renal diseases","volume":"125","author":"Kaschina","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.metabol.2019.03.006_bb0045","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/01.HYP.9.5.429","article-title":"Effects of the cold pressor test on muscle sympathetic nerve activity in humans","volume":"9","author":"Victor","year":"1987","journal-title":"Hypertension."},{"key":"10.1016\/j.metabol.2019.03.006_bb0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2008.01981.x","article-title":"Renin-angiotensin system revisited","volume":"264","author":"Fyhrquist","year":"2008","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2019.03.006_bb0055","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/01.HYP.35.6.1270","article-title":"Physiology and pathophysiology of the adipose tissue renin-angiotensin system","volume":"35","author":"Engeli","year":"2000","journal-title":"Hypertension."},{"key":"10.1016\/j.metabol.2019.03.006_bb0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0031-1295412","article-title":"Primary aldosteronism and metabolic syndrome","volume":"44","author":"Fallo","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.metabol.2019.03.006_bb0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/5584_2018_179","article-title":"Combination therapy of renin angiotensin system inhibitors and beta-blockers in patients with heart failure","volume":"1067","author":"Nochioka","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0070","doi-asserted-by":"crossref","first-page":"685238","DOI":"10.4061\/2011\/685238","article-title":"Role of the renin-angiotensin system and aldosterone on cardiometabolic syndrome","volume":"2011","author":"Stiefel","year":"2011","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.metabol.2019.03.006_bb0075","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1124\/pr.113.008136","article-title":"MAS and its related G protein-coupled receptors","volume":"66","author":"Bader","year":"2014","journal-title":"Mrgprs Pharmacol Rev"},{"key":"10.1016\/j.metabol.2019.03.006_bb0080","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1042\/CS20130333","article-title":"Modulation of the action of insulin by angiotensin-(1\u20137)","volume":"126","author":"Dominici","year":"2014","journal-title":"Clin Sci"},{"key":"10.1016\/j.metabol.2019.03.006_bb0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00109-013-1087-0","article-title":"Oral administration of angiotensin-(1\u20137) ameliorates type 2 diabetes in rats","volume":"92","author":"Santos","year":"2014","journal-title":"J Mol Med"},{"key":"10.1016\/j.metabol.2019.03.006_bb0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.peptides.2014.04.021","article-title":"Angiotensin II and 1\u20137 during aging in metabolic syndrome rats. Expression of AT1, AT2 and Mas receptors in abdominal white adipose tissue","volume":"57","author":"Rubio-Ruiz","year":"2014","journal-title":"Peptides."},{"key":"10.1016\/j.metabol.2019.03.006_bb0095","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00592-011-0348-z","article-title":"Angiotensin-(1\u20137) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes","volume":"49","author":"Liu","year":"2012","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.regpep.2012.06.009","article-title":"Increased circulating angiotensin-(1\u20137) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet","volume":"178","author":"Santos","year":"2012","journal-title":"Regul Pept"},{"key":"10.1016\/j.metabol.2019.03.006_bb0105","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2337\/db12-0792","article-title":"Angiotensin 1\u20137 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model","volume":"62","author":"Marcus","year":"2013","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2019.03.006_bb0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.diabet.2007.09.004","article-title":"Adipokines: the missing link between insulin resistance and obesity","volume":"34","author":"Antuna-Puente","year":"2008","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.metabol.2019.03.006_bb0115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/bph.12159","article-title":"ACE2, angiotensin-(1\u20137) and Mas receptor axis in inflammation and fibrosis","volume":"169","author":"Simoes e Silva","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/15748847112079990050","article-title":"The therapeutic role of renin-angiotensin system blockers in obesity- related renal disorders","volume":"9","author":"Santos","year":"2014","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0125","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/21623945.2015.1131881","article-title":"ACE2\/Ang 1\u20137 axis: a critical regulator of epicardial adipose tissue inflammation and cardiac dysfunction in obesity","volume":"5","author":"Patel","year":"2016","journal-title":"Adipocyte"},{"key":"10.1016\/j.metabol.2019.03.006_bb0130","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0895-7061(02)02257-4","article-title":"Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects","volume":"15","author":"Giacchetti","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.metabol.2019.03.006_bb0135","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2337\/db07-0953","article-title":"Mas deficiency in FVB\/N mice produces marked changes in lipid and glycemic metabolism","volume":"57","author":"Santos","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2019.03.006_bb0140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11154-014-9301-0","article-title":"Adipocyte dysfunction, inflammation and metabolic syndrome","volume":"15","author":"Kloting","year":"2014","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.metabol.2019.03.006_bb0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.beem.2013.02.005","article-title":"Adipose tissue dysfunction contributes to obesity related metabolic diseases","volume":"27","author":"Bluher","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.03.006_bb0150","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2019.03.006_bb0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.metabol.2014.10.016","article-title":"From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century","volume":"64","author":"Bluher","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2019.03.006_bb0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2217\/dmt.13.35","article-title":"Importance of adipokines in glucose homeostasis","volume":"3","author":"Bl\u00fcher","year":"2013","journal-title":"Diabetes Manage"},{"key":"10.1016\/j.metabol.2019.03.006_bb0165","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.molmet.2014.01.005","article-title":"Adipokines - removing road blocks to obesity and diabetes therapy","volume":"3","author":"Bluher","year":"2014","journal-title":"Mol Metab"},{"key":"10.1016\/j.metabol.2019.03.006_bb0170","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1192044","article-title":"Adipose tissue dysfunction in obesity","volume":"117","author":"Bluher","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.metabol.2019.03.006_bb0175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/prca.201100052","article-title":"Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders","volume":"6","author":"Lehr","year":"2012","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.metabol.2019.03.006_bb0180","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.metabol.2013.06.004","article-title":"Adipocytokines in relation to cardiovascular disease","volume":"62","author":"Van de Voorde","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2019.03.006_bb0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.00015.2003","article-title":"Brown adipose tissue: function and physiological significance","volume":"84","author":"Cannon","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.metabol.2019.03.006_bb0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1172\/JCI62308","article-title":"Brown adipose tissue regulates glucose homeostasis and insulin sensitivity","volume":"123","author":"Stanford","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2019.03.006_bb0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4161\/adip.18951","article-title":"Brown adipose tissue: recent insights into development, metabolic function and therapeutic potential","volume":"1","author":"Townsend","year":"2012","journal-title":"Adipocyte"},{"key":"10.1016\/j.metabol.2019.03.006_bb0200","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj2430281","article-title":"Direct assessment of brown adipose tissue as a site of systemic tri-iodothyronine production in the rat","volume":"243","author":"Fernandez","year":"1987","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2019.03.006_bb0205","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0300-9084(80)80030-7","article-title":"Perinatal variations of prostaglandins E2 and F alpha levels in brown adipose tissue of the rat; effects of ambient temperature","volume":"62","author":"Portet","year":"1980","journal-title":"Biochimie."},{"key":"10.1016\/j.metabol.2019.03.006_bb0210","first-page":"E860","article-title":"Role of angiotensin II in brown adipose thermogenesis during cold acclimation","volume":"265","author":"Cassis","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0215","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-5793(97)00671-6","article-title":"Beta-adrenergic stimulation of interleukin-1alpha and interleukin-6 expression in mouse brown adipocytes","volume":"411","author":"Burysek","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.metabol.2019.03.006_bb0220","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2337\/db11-0510","article-title":"Reversal of type 1 diabetes in mice by brown adipose tissue transplant","volume":"61","author":"Gunawardana","year":"2012","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2019.03.006_bb0225","doi-asserted-by":"crossref","first-page":"30147","DOI":"10.1074\/jbc.273.46.30147","article-title":"Ambient temperature regulation of apoptosis in brown adipose tissue. Erk1\/2 promotes norepinephrine-dependent cell survival","volume":"273","author":"Lindquist","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2019.03.006_bb0230","doi-asserted-by":"crossref","first-page":"R623","DOI":"10.1152\/ajpregu.00310.2001","article-title":"Enhanced gene expression of endothelial nitric oxide synthase in brown adipose tissue during cold exposure","volume":"282","author":"Kikuchi-Utsumi","year":"2002","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0235","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2119\/molmed.2011.00075","article-title":"Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21","volume":"17","author":"Chartoumpekis","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.metabol.2019.03.006_bb0240","doi-asserted-by":"crossref","first-page":"E262","DOI":"10.1152\/ajpendo.00271.2013","article-title":"Metabolic remodeling of white adipose tissue in obesity","volume":"307","author":"Cummins","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.03.006_bb0245","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1096\/fj.13-245415","article-title":"Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice","volume":"28","author":"Armani","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2019.03.006_bb0250","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1101\/gad.211649.112","article-title":"Adaptive thermogenesis in adipocytes: is beige the new brown?","volume":"27","author":"Wu","year":"2013","journal-title":"Genes Dev"},{"key":"10.1016\/j.metabol.2019.03.006_bb0255","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.tem.2016.06.006","article-title":"White adipose tissue browning: a double-edged sword","volume":"27","author":"Abdullahi","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.03.006_bb0260","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.metabol.2017.11.009","article-title":"Exercise-induced \u2018browning\u2019 of adipose tissues","volume":"81","author":"Aldiss","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2019.03.006_bb0265","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrendo.2013.204","article-title":"Adipose tissue browning and metabolic health","volume":"10","author":"Bartelt","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0270","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.redox.2017.04.011","article-title":"Metabolic regulation and the anti-obesity perspectives of human brown fat","volume":"12","author":"Scheele","year":"2017","journal-title":"Redox Biol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0275","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bbrc.2019.01.111","article-title":"The novel adipokine CTRP5 is a negative regulator of white adipose tissue browning","volume":"510","author":"Rao","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2019.03.006_bb0280","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4093\/dmj.2012.36.5.317","article-title":"Clinical relevance of adipokines","volume":"36","author":"Bluher","year":"2012","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.metabol.2019.03.006_bb0285","doi-asserted-by":"crossref","first-page":"R943","DOI":"10.1152\/ajpregu.00265.2004","article-title":"Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension","volume":"287","author":"Boustany","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0290","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11906-008-0019-9","article-title":"Local adipose tissue renin-angiotensin system","volume":"10","author":"Cassis","year":"2008","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.metabol.2019.03.006_bb0295","doi-asserted-by":"crossref","first-page":"E262","DOI":"10.1152\/ajpendo.90678.2008","article-title":"Chronic infusion of angiotensin-(1\u20137) improves insulin resistance and hypertension induced by a high-fructose diet in rats","volume":"296","author":"Giani","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.03.006_bb0300","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/ATVBAHA.109.200493","article-title":"Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1\u20137)","volume":"30","author":"Santos","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0305","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.foodchem.2013.03.085","article-title":"Thermogenesis is involved in the body-fat lowering effects of resveratrol in rats","volume":"141","author":"Alberdi","year":"2013","journal-title":"Food Chem"},{"key":"10.1016\/j.metabol.2019.03.006_bb0310","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1210\/en.2004-1427","article-title":"Apelin, a newly identified adipokine up-regulated by insulin and obesity","volume":"146","author":"Boucher","year":"2005","journal-title":"Endocrinology."},{"key":"10.1016\/j.metabol.2019.03.006_bb0315","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10557-010-6274-4","article-title":"Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes","volume":"25","author":"Hung","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.metabol.2019.03.006_bb0320","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/sj.ki.5001810","article-title":"Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation","volume":"70","author":"Kurata","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2019.03.006_bb0325","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1476-5381.2012.02192.x","article-title":"The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition","volume":"168","author":"Siddiquee","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0330","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.98.22.2453","article-title":"Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms","volume":"98","author":"Nickenig","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2019.03.006_bb0335","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.numecd.2016.07.013","article-title":"Renin-angiotensin system at the crossroad of hypertension and hypercholesterolemia","volume":"27","author":"Borghi","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.metabol.2019.03.006_bb0340","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jnutbio.2017.06.008","article-title":"Obesity and malnutrition similarly alter the renin-angiotensin system and inflammation in mice and human adipose","volume":"48","author":"Pinheiro","year":"2017","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.metabol.2019.03.006_bb0345","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrendo.2012.49","article-title":"Muscles, exercise and obesity: skeletal muscle as a secretory organ","volume":"8","author":"Pedersen","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0350","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tips.2007.02.002","article-title":"Beneficial health effects of exercise\u2014the role of IL-6 as a myokine","volume":"28","author":"Pedersen","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.metabol.2019.03.006_bb0355","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.90100.2007","article-title":"Muscle as an endocrine organ: focus on muscle-derived interleukin-6","volume":"88","author":"Pedersen","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.metabol.2019.03.006_bb0360","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.peptides.2013.05.010","article-title":"Oral angiotensin-(1\u20137) prevented obesity and hepatic inflammation by inhibition of resistin\/TLR4\/MAPK\/NF-kappaB in rats fed with high-fat diet","volume":"46","author":"Santos","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.metabol.2019.03.006_bb0365","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.peptides.2014.03.006","article-title":"Cross talk between angiotensin-(1\u20137)\/Mas axis and sirtuins in adipose tissue and metabolism of high-fat feed mice","volume":"55","author":"Oliveira Andrade","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.metabol.2019.03.006_bb0370","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2337\/db15-0399","article-title":"ACE2 deficiency worsens epicardial adipose tissue inflammation and cardiac dysfunction in response to diet-induced obesity","volume":"65","author":"Patel","year":"2016","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2019.03.006_bb0375","first-page":"24","article-title":"Angiotensin-(1\u20137)\/Mas axis and vascular inflammation","volume":"11","author":"Yang","year":"2015","journal-title":"Eur Sci J"},{"key":"10.1016\/j.metabol.2019.03.006_bb0380","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00011-015-0805-1","article-title":"ACE2 and Ang-(1\u20137) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response","volume":"64","author":"Zhang","year":"2015","journal-title":"Inflamm Res"},{"key":"10.1016\/j.metabol.2019.03.006_bb0385","first-page":"3511","article-title":"Angiotensin 1\u20137 ameliorates caerulein-induced inflammation in pancreatic acinar cells by downregulating Toll-like receptor 4\/nuclear factor-kappaB expression","volume":"17","author":"Wang","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.metabol.2019.03.006_bb0390","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/jcp.22940","article-title":"Angiotensin-(1\u20137) decreases LPS-induced inflammatory response in macrophages","volume":"227","author":"Souza","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0395","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00011-012-0571-2","article-title":"Angiotensin (1\u20137) ameliorates angiotensin II-induced inflammation by inhibiting LOX-1 expression","volume":"62","author":"Wang","year":"2013","journal-title":"Inflamm Res"},{"key":"10.1016\/j.metabol.2019.03.006_bb0400","article-title":"The protective arm of the renin-angiotensin system may counteract the intense inflammatory process in fetuses with posterior urethral valves","author":"Rocha","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.metabol.2019.03.006_bb0405","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/jdi.12603","volume":"8","author":"Lei","year":"2017","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.metabol.2019.03.006_bb0410","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3390\/ijms18071392","article-title":"Adipokines in liver cirrhosis","volume":"18","author":"Buechler","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2019.03.006_bb0415","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/ijc.28105","article-title":"Obesity, adipokines and hepatocellular carcinoma","volume":"133","author":"Duan","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.metabol.2019.03.006_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110405","article-title":"Adiponectin agonist ADP355 attenuates CCl4-induced liver fibrosis in mice","volume":"9","author":"Kumar","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2019.03.006_bb0425","doi-asserted-by":"crossref","first-page":"19445","DOI":"10.1038\/srep19445","article-title":"Adiponectin-derived active peptide ADP355 exerts anti-inflammatory and anti-fibrotic activities in thioacetamide-induced liver injury","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2019.03.006_bb0430","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/hepr.12707","article-title":"Angiotensin-(1\u20137) improves non-alcoholic steatohepatitis through an adiponectin-independent mechanism","volume":"47","author":"Tang","year":"2017","journal-title":"Hepatol Res"},{"key":"10.1016\/j.metabol.2019.03.006_bb0435","first-page":"134","article-title":"Inhibitory effect of angiotensin II receptor antagonist on the contraction and growth of hepatic stellate cells","volume":"42","author":"Baik","year":"2003","journal-title":"Korean J Gastroenterol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0440","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jhep.2007.03.008","article-title":"Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1\u20137) levels in experimental biliary fibrosis","volume":"47","author":"Herath","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0445","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1053\/gast.2002.36561","article-title":"Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver","volume":"123","author":"Paizis","year":"2002","journal-title":"Gastroenterology."},{"key":"10.1016\/j.metabol.2019.03.006_bb0450","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3904\/kjim.2017.317","article-title":"Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension","volume":"33","author":"Shim","year":"2018","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.metabol.2019.03.006_bb0455","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/hep.23104","article-title":"Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice","volume":"50","author":"Osterreicher","year":"2009","journal-title":"Hepatology."},{"key":"10.1016\/j.metabol.2019.03.006_bb0460","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/CS20080647","article-title":"Angiotensin-(1\u20137), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat","volume":"117","author":"Lubel","year":"2009","journal-title":"Clin Sci"},{"key":"10.1016\/j.metabol.2019.03.006_bb0465","doi-asserted-by":"crossref","first-page":"e0190863","DOI":"10.1371\/journal.pone.0190863","article-title":"\u03b2-Cell-specific overexpression of adiponectin receptor 1 does not improve diabetes mellitus in Akita mice","volume":"13","author":"Choi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2019.03.006_bb0470","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature."},{"key":"10.1016\/j.metabol.2019.03.006_bb0475","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0016-5085(03)00695-4","article-title":"Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II","volume":"125","author":"Bataller","year":"2003","journal-title":"Gastroenterology."},{"key":"10.1016\/j.metabol.2019.03.006_bb0480","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/hep.28693","article-title":"Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: phase 2 trial","volume":"64","author":"Suk","year":"2016","journal-title":"Hepatology."},{"key":"10.1016\/j.metabol.2019.03.006_bb0485","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0016-5085(00)70368-4","article-title":"Angiotensin II induces contraction and proliferation of human hepatic stellate cells","volume":"118","author":"Bataller","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2019.03.006_bb0490","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1172\/JCI18212","article-title":"NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis","volume":"112","author":"Bataller","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2019.03.006_bb0495","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2013.10.014","article-title":"MicroRNA-150 inhibits expression of adiponectin receptor 2 and is a potential therapeutic target in patients with chronic heart failure","volume":"33","author":"Kreth","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.metabol.2019.03.006_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178769","article-title":"Alamandine reduces leptin expression through the c-Src\/p38 MAP kinase pathway in adipose tissue","volume":"12","author":"Uchiyama","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2019.03.006_bb0505","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1111\/bph.13172","article-title":"Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1\u20137)\/Mas-dependent pathway","volume":"172","author":"Schuchard","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0510","doi-asserted-by":"crossref","first-page":"R1323","DOI":"10.1152\/ajpregu.00249.2013","article-title":"Mas receptor deficiency is associated with worsening of lipid profile and severe hepatic steatosis in ApoE-knockout mice","volume":"305","author":"Silva","year":"2013","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11005\/jbm.2017.24.1.1","article-title":"Role of the cytokine-like hormone leptin in muscle-bone crosstalk with aging","volume":"24","author":"Hamrick","year":"2017","journal-title":"J Bone Metab"},{"key":"10.1016\/j.metabol.2019.03.006_bb0520","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrneph.2017.157","article-title":"Immunologic and endocrine functions of adipose tissue: implications for kidney disease","volume":"14","author":"Zhu","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0525","author":"Alhasson"},{"key":"10.1016\/j.metabol.2019.03.006_bb0530","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/01.HYP.0000141438.64887.42","article-title":"Nonpeptide AVE 0991 is an angiotensin-(1\u20137) receptor Mas agonist in the mouse kidney","volume":"44","author":"Pinheiro","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2019.03.006_bb0535","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2019.03.006_bb0540","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1161\/HYPERTENSIONAHA.118.11127","article-title":"Neuronal SOCS3 (suppressor of cytokine signaling 3): role in modulating chronic metabolic and cardiovascular effects of leptin","volume":"71","author":"do Carmo","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2019.03.006_bb0545","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.113.301077","article-title":"Discovery and characterization of alamandine: a novel component of the renin-angiotensin system","volume":"112","author":"Lautner","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2019.03.006_bb0550","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00726-018-2583-x","article-title":"Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats","volume":"50","author":"Liu","year":"2018","journal-title":"Amino Acids"},{"key":"10.1016\/j.metabol.2019.03.006_bb0555","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/31474","article-title":"A nutrient-sensing pathway regulates leptin gene expression in muscle and fat","volume":"393","author":"Wang","year":"1998","journal-title":"Nature."},{"key":"10.1016\/j.metabol.2019.03.006_bb0560","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ijcard.2016.07.054","article-title":"Potential beneficial effect of some adipokines positively correlated with the adipose tissue content on the cardiovascular system","volume":"222","author":"Sawicka","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0565","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2019.03.006_bb0570","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4093\/dmj.2013.37.6.404","article-title":"Resistin in rodents and humans","volume":"37","author":"Park","year":"2013","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.metabol.2019.03.006_bb0575","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1172\/JCI200421270","article-title":"Role of resistin in diet-induced hepatic insulin resistance","volume":"114","author":"Muse","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2019.03.006_bb0580","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1210\/en.2016-1247","article-title":"The angiotensin-(1\u20137)\/Mas axis improves pancreatic beta-cell function in vitro and in vivo","volume":"157","author":"Sahr","year":"2016","journal-title":"Endocrinology."},{"key":"10.1016\/j.metabol.2019.03.006_bb0585","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.2353\/ajpath.2006.060081","article-title":"Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells","volume":"169","author":"Bertolani","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0590","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.jacc.2011.11.064","article-title":"Discovery of a new role of human resistin in hepatocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subtilisin\/kexin type 9","volume":"59","author":"Melone","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0595","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbrc.2003.09.061","article-title":"Resistin is expressed in pancreatic islets","volume":"310","author":"Minn","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2019.03.006_bb0600","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1249\/MSS.0000000000001570","article-title":"Abdominal muscle density is inversely related to adiposity inflammatory mediators","volume":"50","author":"Van","year":"2018","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.metabol.2019.03.006_bb0605","first-page":"267","article-title":"Is there a relationship between resistin levels and left ventricular end-diastolic pressure?","volume":"19","author":"Y\u0131ld\u0131r\u0131m","year":"2018","journal-title":"Anadulu Kardiyoloji Dergisi: AKD"},{"key":"10.1016\/j.metabol.2019.03.006_bb0610","first-page":"E1253","article-title":"Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action","volume":"290","author":"Yang","year":"2006","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0615","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-2008-1040457","article-title":"Experimental models of hepatic fibrosis: a review","author":"Tsukamoto","year":"1990","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.metabol.2019.03.006_bb0620","doi-asserted-by":"crossref","first-page":"H1205","DOI":"10.1152\/ajpheart.00850.2009","article-title":"Angiotensin-(1\u20137) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats","volume":"299","author":"Costa","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0625","first-page":"e148","article-title":"Effects of the inflammatory response on serum omentin levels in early acute and chronic pancreatitis","volume":"165","author":"Sit","year":"2014","journal-title":"Clin Ter"},{"key":"10.1016\/j.metabol.2019.03.006_bb0630","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/iep.12220","article-title":"Experimental type 2 diabetes induction reduces serum vaspin, but not serum omentin, in Wistar rats","volume":"98","author":"Castro","year":"2017","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0635","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.2337\/db07-0784","article-title":"Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications","volume":"56","author":"Devaraj","year":"2007","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2019.03.006_bb0640","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.tcm.2007.09.005","article-title":"The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives","volume":"17","author":"Gualillo","year":"2007","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.metabol.2019.03.006_bb0645","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1743-7075-7-27","article-title":"Circulating omentin concentration increases after weight loss","volume":"7","author":"Moreno-Navarrete","year":"2010","journal-title":"Nutr Metab"},{"key":"10.1016\/j.metabol.2019.03.006_bb0650","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/1119-3077.181350","article-title":"Serum obestatin and omentin levels in patients with diabetic nephropathy","volume":"20","author":"Zorlu","year":"2017","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.metabol.2019.03.006_bb0655","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/oby.21832","article-title":"Omentin treatment of epicardial fat improves its anti-inflammatory activity and paracrine benefit on smooth muscle cells","volume":"25","author":"Fernandez-Trasancos","year":"2017","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2019.03.006_bb0660","first-page":"1","article-title":"Interactive effects of apelin, renin-angiotensin system and nitric oxide in treatment of obesity-induced type 2 diabetes mellitus in male albino rats","author":"Sabry","year":"2018","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.metabol.2019.03.006_bb0665","doi-asserted-by":"crossref","first-page":"896861","DOI":"10.1155\/2015\/896861","article-title":"The ACE2\/apelin signaling, microRNAs, and hypertension","volume":"2015","author":"Chen","year":"2015","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.metabol.2019.03.006_bb0670","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1002\/jcp.26339","article-title":"Apelin\/APJ system: a critical regulator of vascular smooth muscle cell","volume":"233","author":"Luo","year":"2018","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0675","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/FJC.0000000000000563","article-title":"Apelin reduces nitric oxide-induced relaxation of cerebral arteries by inhibiting activation of large-conductance, calcium-activated K channels","volume":"71","author":"Mughal","year":"2018","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0680","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.acthis.2018.01.007","article-title":"Apelin\/APJ expression in the heart and kidneys of hypertensive rats","volume":"120","author":"Sekerci","year":"2018","journal-title":"Acta Histochem"},{"key":"10.1016\/j.metabol.2019.03.006_bb0685","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1111\/jcmm.12619","article-title":"Apelin promotes diabetic nephropathy by inducing podocyte dysfunction via inhibiting proteasome activities","volume":"19","author":"Guo","year":"2015","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.metabol.2019.03.006_bb0690","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1002\/jcp.26144","article-title":"Apelin\/APJ system: a novel potential therapy target for kidney disease","volume":"233","author":"Huang","year":"2018","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0695","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/MPA.0000000000000740","article-title":"Apelin regulates nuclear factor-kappaB's involvement in the inflammatory response of pancreatitis","volume":"46","author":"Han","year":"2017","journal-title":"Pancreas."},{"key":"10.1016\/j.metabol.2019.03.006_bb0700","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ijo.2013.158","article-title":"Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine","volume":"38","author":"Besse-Patin","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.metabol.2019.03.006_bb0705","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2019.03.006_bb0710","series-title":"Global report on diabetes","author":"Organization WH","year":"2016"},{"key":"10.1016\/j.metabol.2019.03.006_bb0715","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.metabol.2019.03.006_bb0720","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18050944","article-title":"Effect of high glucose levels on white adipose cells and adipokines-fuel for the fire","volume":"18","author":"Sorisky","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2019.03.006_bb0725","doi-asserted-by":"crossref","first-page":"8095926","DOI":"10.1155\/2017\/8095926","article-title":"Adipokines: potential therapeutic targets for vascular dysfunction in type II diabetes mellitus and obesity","volume":"2017","author":"El Husseny","year":"2017","journal-title":"J Diabetes Res"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2019.03.006_bb0730","doi-asserted-by":"crossref","first-page":"S273","DOI":"10.1016\/j.dsx.2016.12.043","article-title":"Adipocytokines and anthropometric measures in type 2 diabetics","volume":"11","author":"Harke","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.metabol.2019.03.006_bb0735","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.biopha.2017.07.059","article-title":"MicroRNAs and adipocytokines: promising biomarkers for pharmacological targets in diabetes mellitus and its complications","volume":"93","author":"Ashoori","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.metabol.2019.03.006_bb0740","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/HYPERTENSIONAHA.117.10280","article-title":"Favorable vascular actions of angiotensin-(1\u20137) in human obesity","volume":"71","author":"Schinzari","year":"2018","journal-title":"Hypertension."},{"key":"10.1016\/j.metabol.2019.03.006_bb0745","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02638-2017","article-title":"A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension","volume":"51","author":"Hemnes","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.metabol.2019.03.006_bb0750","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40262-013-0072-7","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects","volume":"52","author":"Haschke","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.metabol.2019.03.006_bb0755","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061321","article-title":"Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction","volume":"18","author":"Achari","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2019.03.006_bb0760","doi-asserted-by":"crossref","first-page":"37487","DOI":"10.1074\/jbc.M206083200","article-title":"Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis","volume":"277","author":"Matsuda","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2019.03.006_bb0765","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1161\/01.CIR.0000042707.50032.19","article-title":"Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"106","author":"Okamoto","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2019.03.006_bb0770","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2019.03.006_bb0775","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s40618-018-0845-9","article-title":"Association between systemic leptin and neurotensin concentration in adult individuals with and without type 2 diabetes mellitus","volume":"41","author":"Barchetta","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.metabol.2019.03.006_bb0780","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3904\/kjim.2016.229","article-title":"Linking resistin, inflammation, and cardiometabolic diseases","volume":"32","author":"Park","year":"2017","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.metabol.2019.03.006_bb0785","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5114\/pjp.2017.67583","article-title":"Expression of resistin in the liver of patients with non-alcoholic fatty liver disease","volume":"68","author":"Gierej","year":"2017","journal-title":"Pol J Pathol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0790","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mce.2005.09.012","article-title":"Apelin, a novel adipokine over-produced in obesity: friend or foe?","volume":"245","author":"Castan-Laurell","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.metabol.2019.03.006_bb0795","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cmet.2008.10.003","article-title":"Apelin stimulates glucose utilization in normal and obese insulin-resistant mice","volume":"8","author":"Dray","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2019.03.006_bb0800","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1161\/HYPERTENSIONAHA.116.08916","article-title":"Beneficial effects of Apelin on vascular function in patients with central obesity","volume":"69","author":"Schinzari","year":"2017","journal-title":"Hypertension."},{"key":"10.1016\/j.metabol.2019.03.006_bb0805","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.peptides.2017.12.015","article-title":"Ghrelin regulation of glucose metabolism","volume":"100","author":"Poher","year":"2018","journal-title":"Peptides."},{"key":"10.1016\/j.metabol.2019.03.006_bb0810","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040798","article-title":"Therapeutic potential of targeting the ghrelin pathway","volume":"18","author":"Collden","year":"2017","journal-title":"Int J Mol Sci"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049519300629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049519300629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:19:36Z","timestamp":1758428376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049519300629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":162,"alternative-id":["S0026049519300629"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2019.03.006","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-(1-7), Adipokines and Inflammation","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2019.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}